Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
AAPS Pharmscitech
|
May 10, 2018
Editorial for Theme Issue: Applications of KinetiSol Dispersing for Advanced Amorphous Solid Dispersions
Dave A Miller
Drug Development and Industrial Pharmacy
|
February 28, 2008
Advanced formulation design: improving drug therapies for the management of severe and chronic pain
Dave A Miller, James C Dinunzio, Robert O Williams
AAPS Pharmscitech
|
May 31, 2018
Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review
Daniel J Ellenberger, Dave A Miller, Robert O Williams
Biochimica Et Biophysica Acta. Reviews on Cancer
|
November 4, 2019
Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions
Urvi H Gala, Dave A Miller, Robert O Williams
AAPS Pharmscitech
|
November 12, 2020
Thermally Conductive Excipient Expands KinetiSol® Processing Capabilities
Daniel A Davis, Dave A Miller, Yongchao Su, et al.
International Journal of Pharmaceutics
|
October 9, 2007
Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion
Mamoru Fukuda, Dave A Miller, Nicholas A Peppas, et al.
AAPS Pharmscitech
|
March 16, 2018
Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing
Daniel J Ellenberger, Dave A Miller, Sandra U Kucera, et al.
AAPS Pharmscitech
|
February 12, 2016
Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2)
Chris Brough, Dave A Miller, Daniel Ellenberger, et al.
AAPS Pharmscitech
|
June 6, 2018
Generation of a Weakly Acidic Amorphous Solid Dispersion of the Weak Base Ritonavir with Equivalent In Vitro and In Vivo Performance to Norvir Tablet
Daniel J Ellenberger, Dave A Miller, Sandra U Kucera, et al.
Pharmaceutics
|
June 27, 2025
Comment on Hermeling et al. Nano-Dry-Melting: A Novel Technology for Manufacturing of Pharmaceutical Amorphous Solid Dispersions. <i>Pharmaceutics</i> 2022, <i>14</i>, 2145
Dave A Miller, Sandra U Kucera, Daniel Ellenberger, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
AAPS Pharmscitech
|
May 10, 2018
Editorial for Theme Issue: Applications of KinetiSol Dispersing for Advanced Amorphous Solid Dispersions
Dave A Miller
Drug Development and Industrial Pharmacy
|
February 28, 2008
Advanced formulation design: improving drug therapies for the management of severe and chronic pain
Dave A Miller, James C Dinunzio, Robert O Williams
AAPS Pharmscitech
|
May 31, 2018
Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review
Daniel J Ellenberger, Dave A Miller, Robert O Williams
Biochimica Et Biophysica Acta. Reviews on Cancer
|
November 4, 2019
Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions
Urvi H Gala, Dave A Miller, Robert O Williams
AAPS Pharmscitech
|
November 12, 2020
Thermally Conductive Excipient Expands KinetiSol® Processing Capabilities
Daniel A Davis, Dave A Miller, Yongchao Su, et al.
International Journal of Pharmaceutics
|
October 9, 2007
Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion
Mamoru Fukuda, Dave A Miller, Nicholas A Peppas, et al.
AAPS Pharmscitech
|
March 16, 2018
Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing
Daniel J Ellenberger, Dave A Miller, Sandra U Kucera, et al.
AAPS Pharmscitech
|
February 12, 2016
Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2)
Chris Brough, Dave A Miller, Daniel Ellenberger, et al.
AAPS Pharmscitech
|
June 6, 2018
Generation of a Weakly Acidic Amorphous Solid Dispersion of the Weak Base Ritonavir with Equivalent In Vitro and In Vivo Performance to Norvir Tablet
Daniel J Ellenberger, Dave A Miller, Sandra U Kucera, et al.
Pharmaceutics
|
June 27, 2025
Comment on Hermeling et al. Nano-Dry-Melting: A Novel Technology for Manufacturing of Pharmaceutical Amorphous Solid Dispersions. <i>Pharmaceutics</i> 2022, <i>14</i>, 2145
Dave A Miller, Sandra U Kucera, Daniel Ellenberger, et al.
Page
of 4